Failures in the labeling system lead to a shortage of drugs on the market. Hundreds of millions of packages of medicines have accumulated in warehouses and quarantine zones of the distribution chain. To avoid a collapse, the Government has simplified the procedure for working with the drug monitoring system. The new regime will operate until […]
Press-Center
The XII scientific-practical conference "State regulation and the Russian pharmaceutical industry: continuation of the dialogue", organized by the Association of Russian pharmaceutical manufacturers and the National Research Institute of Public Health named after N.A. Semashko. The event was attended by representatives of regulatory authorities, expert organizations, pharmaceutical companies, medical communities and patient organizations. The discussion […]
2020 was the year of bringing the drug dossier in correspondence with the unified rules of the EAEU, but the COVID-19 pandemic intervened in this process. In the union states, GMP inspection of sites has been temporarily suspended, and in Russia remote methods of checking good manufacturing practices are being introduced. These are not the […]
The pandemic has contributed to the rise in deaths from cardiovascular diseases. In the first half of 2020, almost 40 thousand people died from acute coronary syndrome, and more than 220 thousand people died from coronary heart disease. For many years, cardiovascular disease has been at the top of the mortality statistics rating. Pilot drug […]
The pharmaceutical industry is at the crossroads of interests between healthcare and patients. Its development is one of the state priorities, therefore it is very important to maintain a balance of interests in providing the population with affordable drugs. Today there are many sensitive topics that need to be considered from different points of view […]
On September 25, a lively discussion of experts from the pharmaceutical industry and medicine with representatives of the legislative and executive authorities will take place on the most pressing issues of drug supply to the population in online and offline formats. The forum is held in a mixed format: offline on the site of the […]
COVID-19 has exacerbated many health issues that require a range of amendments and additions to current health legislation. How the coronavirus pandemic affected the provision of medicines to Russians, we will consider together with industry experts, legislators and regulators in a hybrid format within the framework of the Partnership “Medicines of Russia — for an […]
The partnering "Medicines of Russia — for an interdisciplinary dialogue" will take place on September 25 in Kaliningrad. The focus is on the results of the implementation of the Pharma 2020 strategy, the modernization of the drug supply system, pilot projects for drug reimbursement, the availability and safety of drugs, fair competition in the pharmaceutical […]
Dear Colleagues! (And we, at least, are united by our long-term professional work as part of the expert council under the Federal Antimonopoly Service (FAS) for the Development of Competition in the Social Sphere and Healthcare.) With age, I stopped being surprised at the sometimes ridiculous and absurd decisions made by individual officials in the […]
There is a threat of a lack of drugs in Russia, said experts of the round table "Labeling of Medicines" on the air of the radio "Komsomolskaya Pravda". Since July 1, the mandatory labeling of drugs has started, but manufacturers will soon be able to obtain permission from the interdepartmental commission and produce drugs without […]